✦ LIBER ✦

A comparative study of bisantrene given by two dose schedules in patients with metastatic breast cancer

✍ Scribed by Frankie A. Holmes; Laura Esparza; Hwee Y. Yap; Aman U. Buzdar; R George; Blumenschein; Gabriel N. Hortobagyi

Publisher: Springer
Year: 1986
Tongue: English
Weight: 524 KB
Volume: 18
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00262287

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative pharmacokinetics of doxorubi

Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer

✍ C. J. Twelves; N. A. Dobbs; M. Aldhous; P. G. Harper; R. D. Rubens; M. A. Richar 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 571 KB

Comparative pharmacokinetics of escalati

Comparative pharmacokinetics of escalating doses of doxorubicin in patients with metastatic breast cancer

✍ Miguel H. Bronchud; Jennifer M. Margison; Anthony Howell; Michael Lind; Samuel B 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 472 KB

Phase 2 trial of a novel capecitabine do

Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer

✍ Devika Gajria; Kim Feigin; Lee K. Tan; Sujata Patil; Stephanie Geneus; Maria The 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

Multiple-dose pharmacokinetics of epirub

Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer

✍ Preben Jakobsen; Eva Steiness; Lars Bastholt; Mads Dalmark; Anders Lorenzen; Dor 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 549 KB

Pharmacokinetics of 4′-O-tetrahydropyran

Pharmacokinetics of 4′-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer

✍ Robert M. Mader; Harald Zilg; Otto Schlappack; Günther G. Steger; Martina Baur; 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 652 KB

Methylprednisolone as antiemetic treatme

Methylprednisolone as antiemetic treatment in breast-cancer patients receiving cyclophosphamide, methotrexate, and 5-fluorouracil: a prospective, crossover, randomized blind study comparing two different dose schedules

✍ Eliahu Gez; Nurith Strauss; Nehama Vitzhaki; Yaakov Cass; David Zvi Edelmann 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 362 KB